Uncategorized

Accelerated approval for OMS721 in HSCT-TMA — Bio Deepdive

After receiving Breakthrough Therapy designation for OMS721 in HSCT-TMA, the company just announced that they are in discussion with the FDA for an accelerated approval in this indication and therefore will soon be initiating a rolling BLA submission. The update comes after Omeros had reported very encouraging date with the complement inhibitor in 19 stem […]

via Accelerated approval for OMS721 in HSCT-TMA — Bio Deepdive

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s